Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/7614
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moore, D. | - |
dc.contributor.author | Tao, B. | - |
dc.contributor.author | Lines, D. | - |
dc.contributor.author | Hirte, C. | - |
dc.contributor.author | Heddle, M. | - |
dc.contributor.author | Davidson, G. | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Journal of Pediatrics, 2003; 143(2):219-223 | - |
dc.identifier.issn | 0022-3476 | - |
dc.identifier.issn | 1097-6833 | - |
dc.identifier.uri | http://hdl.handle.net/2440/7614 | - |
dc.description.abstract | <h4>Objective</h4>To assess the efficacy of omeprazole in treating irritable infants with gastroesophageal reflux and/or esophagitis.<h4>Study design</h4>Irritable infants (n=30) 3 to 12 months of age met the entry criteria of esophageal acid exposure >5% (n=22) and/or abnormal esophageal histology (n=15). They completed a 4-week, randomized, double-blind, placebo-controlled crossover trial of omeprazole. Cry/fuss diary (minutes/24 hours) and a visual analogue scale of infant irritability as judged by parental impression were obtained at baseline and the end of each 2-week treatment period.<h4>Results</h4>The reflux index fell significantly during omeprazole treatment compared with placebo (-8.9%+/-5.6%, -1.9%+/-2.0%, P<.001). Cry/fuss time decreased from baseline (267+/-119), regardless of treatment sequence (period 1, 203+/-99, P<.04; period 2, 188+/-121, P<.008). Visual analogue score decreased from baseline to period 2 (6.8+/-1.6, 4.8+/-2.9, P=.008). There was no significant difference for both outcome measures while taking either omeprazole or placebo.<h4>Conclusions</h4>Compared with placebo, omeprazole significantly reduced esophageal acid exposure but not irritability. Irritability improved with time, regardless of treatment. | - |
dc.description.statementofresponsibility | Moore, David John ; Tao, Billy Siang-Kuo ; Lines, David Robin ; Hirte, Craig ; Heddle, Margaret Lila ; Davidson, Geoffrey Paul | - |
dc.language.iso | en | - |
dc.publisher | Mosby Inc | - |
dc.source.uri | http://dx.doi.org/10.1067/s0022-3476(03)00207-5 | - |
dc.subject | Humans | - |
dc.subject | Gastroesophageal Reflux | - |
dc.subject | Esophagitis, Peptic | - |
dc.subject | Omeprazole | - |
dc.subject | Anti-Ulcer Agents | - |
dc.subject | Cross-Over Studies | - |
dc.subject | Double-Blind Method | - |
dc.subject | Infant Behavior | - |
dc.subject | Infant | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.title | Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1067/S0022-3476(03)00207-5 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.